Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis

Xiao-yan Wang, Huan-tao Zong, Yong Zhang Department of Urology, Beijing Tian Tan Hospital, Capital Medical University, Beijing, People’s Republic of China Background: Prostate artery embolization (PAE) is emerging and is a promising minimally invasive therapy that improves lower urinary...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang XY, Zong HT, Zhang Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/bcaaa92019db4b4793c574c87b568886
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bcaaa92019db4b4793c574c87b568886
record_format dspace
spelling oai:doaj.org-article:bcaaa92019db4b4793c574c87b5688862021-12-02T09:04:20ZEfficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis1178-1998https://doaj.org/article/bcaaa92019db4b4793c574c87b5688862016-11-01T00:00:00Zhttps://www.dovepress.com/efficacy-and-safety-of-prostate-artery-embolization-on-lower-urina-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Xiao-yan Wang, Huan-tao Zong, Yong Zhang Department of Urology, Beijing Tian Tan Hospital, Capital Medical University, Beijing, People’s Republic of China Background: Prostate artery embolization (PAE) is emerging and is a promising minimally invasive therapy that improves lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH). The purpose of this article was to evaluate the efficacy and safety of PAE on LUTS related to BPH. Materials and methods: A literature review was performed to identify all published articles of PAE for BPH. The sources included MEDLINE, EMBASE and Cochrane Library from 1980 to 2016. A systematic review and meta-analysis was conducted. The outcome measurements were combined by calculating the mean difference with 95% confidence interval. Statistical analysis was carried out using Review Manager 5.3.0. Results: Twelve studies involving 840 participants were included. Compared with baseline, the International Index of Erectile Function (IIEF-5; International Prostate Symptom Score) scores, the quality of life scores, peak urinary flow rate (Qmax) and postvoid residual volume all had significant improvements during the 24-month follow-up (all P<0.00001). Both prostate volume (PV) and prostate-specific antigen had significant decrease during the 12-month follow-up (P<0.00001 and P=0.005, respectively), except postoperative 24 months (P=0.47 and P=0.32, respectively). The IIEF-5 short form scores had significant increase at postoperative 6 months (P=0.002) and 12 months (P<0.0001), except postoperative 1 month (P=0.23) and 24 months (P=0.21). For large volume (PV ≥80 mL) BPH, the results were similar. There were no life-threatening complications. Conclusion: PAE is an effective, safe and well-tolerable treatment for LUTS related to BPH, including large volume (PV ≥80 mL) BPH, with a good short-term follow-up. Studies with large number of cases and longer follow-up time are needed to validate our results. Keywords: lower urinary tract symptoms, benign prostatic hyperplasia, meta-analysis, prostate artery embolizationWang XYZong HTZhang YDove Medical Pressarticlelower urinary tract symptomsbenign prostatic hyperplasiameta-analysisprostate artery embolizationGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 11, Pp 1609-1622 (2016)
institution DOAJ
collection DOAJ
language EN
topic lower urinary tract symptoms
benign prostatic hyperplasia
meta-analysis
prostate artery embolization
Geriatrics
RC952-954.6
spellingShingle lower urinary tract symptoms
benign prostatic hyperplasia
meta-analysis
prostate artery embolization
Geriatrics
RC952-954.6
Wang XY
Zong HT
Zhang Y
Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
description Xiao-yan Wang, Huan-tao Zong, Yong Zhang Department of Urology, Beijing Tian Tan Hospital, Capital Medical University, Beijing, People’s Republic of China Background: Prostate artery embolization (PAE) is emerging and is a promising minimally invasive therapy that improves lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH). The purpose of this article was to evaluate the efficacy and safety of PAE on LUTS related to BPH. Materials and methods: A literature review was performed to identify all published articles of PAE for BPH. The sources included MEDLINE, EMBASE and Cochrane Library from 1980 to 2016. A systematic review and meta-analysis was conducted. The outcome measurements were combined by calculating the mean difference with 95% confidence interval. Statistical analysis was carried out using Review Manager 5.3.0. Results: Twelve studies involving 840 participants were included. Compared with baseline, the International Index of Erectile Function (IIEF-5; International Prostate Symptom Score) scores, the quality of life scores, peak urinary flow rate (Qmax) and postvoid residual volume all had significant improvements during the 24-month follow-up (all P<0.00001). Both prostate volume (PV) and prostate-specific antigen had significant decrease during the 12-month follow-up (P<0.00001 and P=0.005, respectively), except postoperative 24 months (P=0.47 and P=0.32, respectively). The IIEF-5 short form scores had significant increase at postoperative 6 months (P=0.002) and 12 months (P<0.0001), except postoperative 1 month (P=0.23) and 24 months (P=0.21). For large volume (PV ≥80 mL) BPH, the results were similar. There were no life-threatening complications. Conclusion: PAE is an effective, safe and well-tolerable treatment for LUTS related to BPH, including large volume (PV ≥80 mL) BPH, with a good short-term follow-up. Studies with large number of cases and longer follow-up time are needed to validate our results. Keywords: lower urinary tract symptoms, benign prostatic hyperplasia, meta-analysis, prostate artery embolization
format article
author Wang XY
Zong HT
Zhang Y
author_facet Wang XY
Zong HT
Zhang Y
author_sort Wang XY
title Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
title_short Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
title_full Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
title_fullStr Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
title_full_unstemmed Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
title_sort efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/bcaaa92019db4b4793c574c87b568886
work_keys_str_mv AT wangxy efficacyandsafetyofprostatearteryembolizationonlowerurinarytractsymptomsrelatedtobenignprostatichyperplasiaasystematicreviewandmetaanalysis
AT zonght efficacyandsafetyofprostatearteryembolizationonlowerurinarytractsymptomsrelatedtobenignprostatichyperplasiaasystematicreviewandmetaanalysis
AT zhangy efficacyandsafetyofprostatearteryembolizationonlowerurinarytractsymptomsrelatedtobenignprostatichyperplasiaasystematicreviewandmetaanalysis
_version_ 1718398267065106432